PharMerica Corporation
PMC
PMC was delisted on the 7th of December, 2017.
166 hedge funds and large institutions have $736M invested in PharMerica Corporation in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 21 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 55
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 21
4% less funds holding
Funds holding: 173 → 166 (-7)
12% less capital invested
Capital invested by funds: $835M → $736M (-$98.6M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$23.1M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.02M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$5.99M |
| 4 |
DGI
Discovery Group I
Chicago,
Illinois
|
+$5.99M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$3.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$16.2M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$11.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.08M |
| 4 |
Millennium Management
New York
|
-$7.76M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$7.03M |
PMC Hedge Fund Activity: Q4 2016 in Review
166 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q4 2016, worth a combined $736M — down 12% from $835M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of PMC and 19 opened new positions — a net loss of 2 holders — while 55 trimmed existing stakes and 59 added.
The largest buyer was Boston Partners, adding an estimated $23.1M. The largest seller was Balyasny Asset Management, cutting an estimated $16.2M.
- 166 institutional investors held PharMerica Corporation (PMC) as of Q4 2016, down from 173 in Q3 2016.
- Funds reported $736M of PharMerica Corporation stock for Q4 2016, down 12% quarter-over-quarter.
- 19 funds opened new PharMerica Corporation positions in Q4 2016 and 21 closed out, a net change of -2 holders.
- The largest PharMerica Corporation buyer in Q4 2016 was Boston Partners, an estimated $23.1M added.
- The largest PharMerica Corporation seller in Q4 2016 was Balyasny Asset Management, an estimated $16.2M sold.
Based on aggregated 13F filings for Q4 2016.